MedTrace Logo

A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease

NCT07254234 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-11-28

No results posted yet for this study

Summary

The purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research site.

Conditions

  • Cognitive Dysfunction
  • Memory Disorders

Interventions

OTHER

Retinal scan

Detailed image of the retina.

OTHER

Blood test

Sample will be used to test for a specific form of a protein in the blood to learn more about early detection of Alzheimer's disease.

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07254234 on ClinicalTrials.gov